A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis
Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F(2) progeny. Using the F(2) hybrids resulting from an F(1) intercross of a newly identified suscepti...
Saved in:
Published in: | The Journal of immunology (1950) Vol. 165; no. 9; pp. 5278 - 5286 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Am Assoc Immnol
01-11-2000
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F(2) progeny. Using the F(2) hybrids resulting from an F(1) intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F(2) hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN-gamma, IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs. IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2(b) and H-2(k)) of the C3H x C57BL/6 F(2) intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs. |
---|---|
AbstractList | Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F(2) progeny. Using the F(2) hybrids resulting from an F(1) intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F(2) hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN-gamma, IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs. IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2(b) and H-2(k)) of the C3H x C57BL/6 F(2) intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs. Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F2 progeny. Using the F2 hybrids resulting from an F1 intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F2 hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN-γ, IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2b and H-2k) of the C3H × C57BL/6 F2 intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs. Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F sub(2) progeny. Using the F sub(2) hybrids resulting from an F sub(1) intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F sub(2) hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN- gamma , IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2 super(b) and H-2 super(k)) of the C3H x C57BL/6 F sub(2) intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs. |
Author | Glant, Tibor T Otto, Jeffrey M Finnegan, Alison Enders, Jill T Vermes, Csaba Mikecz, Katalin Rickert, Sarah E Chandrasekeran, Raman |
Author_xml | – sequence: 1 fullname: Otto, Jeffrey M – sequence: 2 fullname: Chandrasekeran, Raman – sequence: 3 fullname: Vermes, Csaba – sequence: 4 fullname: Mikecz, Katalin – sequence: 5 fullname: Finnegan, Alison – sequence: 6 fullname: Rickert, Sarah E – sequence: 7 fullname: Enders, Jill T – sequence: 8 fullname: Glant, Tibor T |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11046062$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUFv0zAUxy00xLrBJ0BCPsEpxXYcOz5W1RiTypBYOVtu8rK-KbFL7BDtxkfHVYvgxsWW_H7vr_f8uyIXPngg5C1nS8mk-fiEwzD50C-5qpZmWQldvyALXlWsUIqpC7JgTIiCa6UvyVWMT4wxxYR8RS45ZzIjYkF-regt-DAAfWicp98j-kfq6H34Cf2xAgkbuh5DjPSuBZ-wQ4j0Hmb6MMUGDgl32GN6ppvQIHW-pdvRYYoUfY75EqYI-WxzWOjotz1Mg0sBW7oa037EhPE1edm5PsKb831Ntp9utuvPxebr7d16tSkayUwqjNPGCCFbJ2Qla5236jRUOm9rSl11XAlW11plrOSm5lru8mPHROO04qa8Ju9PsYcx_JggJjtgnr_vnYc8pNWiVMJI8V-Qay2YEVUGyxPYHH9nhM4eRhzc-Gw5s0dB9o8gmwVZY4-Ccte7c_y0G6D923M2koEPJ2CPj_sZR7BxcH2fcW7nef4n6jd9HpwT |
CitedBy_id | crossref_primary_10_4049_jimmunol_181_2_1307 crossref_primary_10_1186_ar624 crossref_primary_10_1038_gene_2012_2 crossref_primary_10_1002_art_11275 crossref_primary_10_4049_jimmunol_175_4_2475 crossref_primary_10_1038_gene_2008_54 crossref_primary_10_1002_art_20366 crossref_primary_10_1002_art_20786 crossref_primary_10_1016_j_mce_2009_07_017 crossref_primary_10_1046_j_1365_3083_2003_01235_x crossref_primary_10_1002_art_20624 crossref_primary_10_1097_00002281_200109000_00003 crossref_primary_10_4049_jimmunol_168_12_6013 crossref_primary_10_1002_1529_0131_200103_44_3_682__AID_ANR118_3_0_CO_2_E crossref_primary_10_1046_j_1365_2249_2002_01903_x crossref_primary_10_4049_jimmunol_170_5_2283 crossref_primary_10_4049_jimmunol_172_11_6723 crossref_primary_10_1002_art_20285 crossref_primary_10_1016_S0002_9440_10_63018_0 crossref_primary_10_1002_art_11016 crossref_primary_10_4049_jimmunol_174_1_435 crossref_primary_10_4049_jimmunol_170_2_1019 crossref_primary_10_4049_jimmunol_166_5_2944 crossref_primary_10_1002_art_20655 crossref_primary_10_1016_S0168_9525_02_02684_7 crossref_primary_10_1097_00000441_200404000_00004 crossref_primary_10_1111_j_0906_6705_2005_00348_x crossref_primary_10_1016_S0888_7543_03_00208_8 crossref_primary_10_1017_S0016672310000704 crossref_primary_10_1038_sj_gene_6364419 crossref_primary_10_1155_2012_284751 crossref_primary_10_1002_art_10555 crossref_primary_10_4049_jimmunol_174_12_7894 crossref_primary_10_1007_s10753_006_8962_6 |
Cites_doi | 10.1172/JCI1817 10.1016/S0092-8674(00)81110-1 10.1046/j.1365-2249.2000.01174.x 10.1136/jmg.33.8.672 10.1038/ng0795-313 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M 10.1002/(SICI)1096-8628(19990507)84:1<15::AID-AJMG4>3.0.CO;2-O 10.1002/jbmr.5650080907 10.4049/jimmunol.162.5.2581 10.1016/S0198-8859(99)00048-8 10.4049/jimmunol.163.5.2916 10.4049/jimmunol.162.4.1917 10.1093/hmg/6.9.1401 10.1073/pnas.95.18.10746 10.1002/art.1780300310 10.1086/302061 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6 10.4049/jimmunol.162.4.2415 10.1086/302767 10.1016/S0952-7915(99)00038-2 10.1038/ng0695-240 10.1006/cimm.1994.1277 10.1093/genetics/139.3.1421 10.1002/art.1780330614 10.1096/fasebj.6.11.1644260 10.2337/diabetes.47.9.1525 10.4049/jimmunol.163.10.5383 10.1073/pnas.95.25.14875 10.4049/jimmunol.160.8.3812 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0 10.1038/3887 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0 10.1016/0008-8749(92)90250-S 10.2337/diabetes.48.5.1175 10.4049/jimmunol.162.2.948 10.1002/1529-0131(199812)41:12<2122::AID-ART7>3.0.CO;2-# 10.1016/S0041-1345(99)00047-0 10.1073/pnas.95.25.14869 10.1093/hmg/5.Supplement_1.1443 10.1016/S0952-7915(98)80090-3 10.1006/geno.1996.0153 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z 10.1016/S0041-1345(99)00052-4 10.1038/ng0996-82 10.1073/pnas.96.5.2210 10.1002/art.1780300211 10.1038/ng0996-90 10.4049/jimmunol.161.8.4411 10.1007/s004390050245 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E 10.1172/JCI118648 10.1038/ng1195-241 10.1073/pnas.95.17.9979 10.1016/0888-7543(87)90010-3 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 8FD FR3 H94 P64 RC3 7X8 |
DOI | 10.4049/jimmunol.165.9.5278 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Genetics Abstracts Immunology Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 5286 |
ExternalDocumentID | 10_4049_jimmunol_165_9_5278 11046062 www165_9_5278 |
Genre | Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: AR-40310 – fundername: NIAMS NIH HHS grantid: AR-45652 |
GroupedDBID | - 08R 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS 79B 85S 8RP AALRV AARDX ABEFU ABFLS ABOCM ABPPZ ABPTK ACGFS ACIWK ACNCT ACPRK ADACO ADBBV ADKFC AENEX AETEA AFFNX AFRAH AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL D0L DIK DU5 E3Z EBS EJD F5P FH7 FRP G8K GJ GX1 IH2 J5H K-O K78 KQ8 L7B MVM MYA NEJ O0- OK1 P0W P2P PQEST PQQKQ R.V RHF RHI RZQ SJN TWZ VH1 WH7 WOQ X X7M XFK XJT YCJ ZA5 ZE2 ZGI ZXP --- -~X .55 .GJ 18M ABCQX ABJNI ACGFO ADNWM AFHIN AFOSN AHWXS AI. AIZAD BTFSW CGR CUY CVF ECM EIF NPM TR2 W8F XSW XTH YHG AAYXX ABDPE CITATION 7T5 8FD FR3 H94 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c409t-9a799224da245487176f7e575509375f16208876a793198174b5f1f02ca76193 |
ISSN | 0022-1767 |
IngestDate | Fri Oct 25 05:47:46 EDT 2024 Fri Oct 25 02:04:09 EDT 2024 Thu Nov 21 23:41:59 EST 2024 Sat Sep 28 08:38:40 EDT 2024 Tue Nov 10 19:50:43 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c409t-9a799224da245487176f7e575509375f16208876a793198174b5f1f02ca76193 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/165/9/5278/1124010/5278.pdf |
PMID | 11046062 |
PQID | 17720925 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_72362942 proquest_miscellaneous_17720925 crossref_primary_10_4049_jimmunol_165_9_5278 pubmed_primary_11046062 highwire_smallpub1_www165_9_5278 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 20001101 2000-Nov-01 2000-11-01 |
PublicationDateYYYYMMDD | 2000-11-01 |
PublicationDate_xml | – month: 11 year: 2000 text: 20001101 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2000 |
Publisher | Am Assoc Immnol |
Publisher_xml | – name: Am Assoc Immnol |
References | 2023010117570289700_R41 2023010117570289700_R40 2023010117570289700_R43 2023010117570289700_R42 2023010117570289700_R45 2023010117570289700_R44 2023010117570289700_R36 2023010117570289700_R35 2023010117570289700_R38 2023010117570289700_R37 2023010117570289700_R39 2023010117570289700_R1 2023010117570289700_R30 2023010117570289700_R4 2023010117570289700_R32 2023010117570289700_R5 2023010117570289700_R31 2023010117570289700_R2 2023010117570289700_R34 2023010117570289700_R3 2023010117570289700_R33 2023010117570289700_R8 2023010117570289700_R9 2023010117570289700_R6 2023010117570289700_R7 2023010117570289700_R25 2023010117570289700_R24 2023010117570289700_R27 2023010117570289700_R26 2023010117570289700_R29 2023010117570289700_R28 2023010117570289700_R61 2023010117570289700_R60 2023010117570289700_R63 2023010117570289700_R62 2023010117570289700_R21 2023010117570289700_R65 2023010117570289700_R20 2023010117570289700_R64 2023010117570289700_R23 2023010117570289700_R22 2023010117570289700_R14 2023010117570289700_R58 2023010117570289700_R13 2023010117570289700_R57 2023010117570289700_R16 2023010117570289700_R15 2023010117570289700_R59 2023010117570289700_R18 2023010117570289700_R17 2023010117570289700_R19 2023010117570289700_R50 2023010117570289700_R52 2023010117570289700_R51 2023010117570289700_R10 2023010117570289700_R54 2023010117570289700_R53 2023010117570289700_R12 2023010117570289700_R56 2023010117570289700_R11 2023010117570289700_R55 2023010117570289700_R47 2023010117570289700_R46 2023010117570289700_R49 2023010117570289700_R48 |
References_xml | – ident: 2023010117570289700_R26 doi: 10.1172/JCI1817 – ident: 2023010117570289700_R16 doi: 10.1016/S0092-8674(00)81110-1 – ident: 2023010117570289700_R49 doi: 10.1046/j.1365-2249.2000.01174.x – ident: 2023010117570289700_R25 doi: 10.1136/jmg.33.8.672 – ident: 2023010117570289700_R28 doi: 10.1038/ng0795-313 – ident: 2023010117570289700_R12 doi: 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M – ident: 2023010117570289700_R40 doi: 10.1002/(SICI)1096-8628(19990507)84:1<15::AID-AJMG4>3.0.CO;2-O – ident: 2023010117570289700_R51 doi: 10.1002/jbmr.5650080907 – ident: 2023010117570289700_R24 doi: 10.4049/jimmunol.162.5.2581 – ident: 2023010117570289700_R41 doi: 10.1016/S0198-8859(99)00048-8 – ident: 2023010117570289700_R14 doi: 10.4049/jimmunol.163.5.2916 – ident: 2023010117570289700_R27 doi: 10.4049/jimmunol.162.4.1917 – ident: 2023010117570289700_R36 doi: 10.1093/hmg/6.9.1401 – ident: 2023010117570289700_R4 doi: 10.1073/pnas.95.18.10746 – ident: 2023010117570289700_R21 doi: 10.1002/art.1780300310 – ident: 2023010117570289700_R37 doi: 10.1086/302061 – ident: 2023010117570289700_R23 doi: 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6 – ident: 2023010117570289700_R47 doi: 10.4049/jimmunol.162.4.2415 – ident: 2023010117570289700_R43 doi: 10.1086/302767 – ident: 2023010117570289700_R19 doi: 10.1016/S0952-7915(99)00038-2 – ident: 2023010117570289700_R30 doi: 10.1038/ng0695-240 – ident: 2023010117570289700_R55 – ident: 2023010117570289700_R50 doi: 10.1006/cimm.1994.1277 – ident: 2023010117570289700_R59 – ident: 2023010117570289700_R1 – ident: 2023010117570289700_R54 doi: 10.1093/genetics/139.3.1421 – ident: 2023010117570289700_R58 doi: 10.1002/art.1780330614 – ident: 2023010117570289700_R5 – ident: 2023010117570289700_R63 doi: 10.1096/fasebj.6.11.1644260 – ident: 2023010117570289700_R38 doi: 10.2337/diabetes.47.9.1525 – ident: 2023010117570289700_R48 doi: 10.4049/jimmunol.163.10.5383 – ident: 2023010117570289700_R45 doi: 10.1073/pnas.95.25.14875 – ident: 2023010117570289700_R22 doi: 10.4049/jimmunol.160.8.3812 – ident: 2023010117570289700_R15 doi: 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0 – ident: 2023010117570289700_R9 doi: 10.1038/3887 – ident: 2023010117570289700_R6 doi: 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0 – ident: 2023010117570289700_R56 – ident: 2023010117570289700_R62 doi: 10.1016/0008-8749(92)90250-S – ident: 2023010117570289700_R39 doi: 10.2337/diabetes.48.5.1175 – ident: 2023010117570289700_R64 doi: 10.4049/jimmunol.162.2.948 – ident: 2023010117570289700_R11 doi: 10.1002/1529-0131(199812)41:12<2122::AID-ART7>3.0.CO;2-# – ident: 2023010117570289700_R2 – ident: 2023010117570289700_R17 doi: 10.1016/S0041-1345(99)00047-0 – ident: 2023010117570289700_R61 – ident: 2023010117570289700_R29 doi: 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0 – ident: 2023010117570289700_R44 doi: 10.1073/pnas.95.25.14869 – ident: 2023010117570289700_R35 doi: 10.1093/hmg/5.Supplement_1.1443 – ident: 2023010117570289700_R46 doi: 10.1016/S0952-7915(98)80090-3 – ident: 2023010117570289700_R32 – ident: 2023010117570289700_R34 doi: 10.1006/geno.1996.0153 – ident: 2023010117570289700_R52 doi: 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z – ident: 2023010117570289700_R8 doi: 10.1016/S0041-1345(99)00052-4 – ident: 2023010117570289700_R10 doi: 10.1038/ng0996-82 – ident: 2023010117570289700_R13 doi: 10.1073/pnas.96.5.2210 – ident: 2023010117570289700_R20 doi: 10.1002/art.1780300211 – ident: 2023010117570289700_R33 doi: 10.1038/ng0996-90 – ident: 2023010117570289700_R7 doi: 10.4049/jimmunol.161.8.4411 – ident: 2023010117570289700_R42 doi: 10.1007/s004390050245 – ident: 2023010117570289700_R3 – ident: 2023010117570289700_R65 doi: 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E – ident: 2023010117570289700_R60 – ident: 2023010117570289700_R31 doi: 10.1172/JCI118648 – ident: 2023010117570289700_R57 doi: 10.1038/ng1195-241 – ident: 2023010117570289700_R18 doi: 10.1073/pnas.95.17.9979 – ident: 2023010117570289700_R53 doi: 10.1016/0888-7543(87)90010-3 |
SSID | ssj0006024 |
Score | 1.8946828 |
Snippet | Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced... |
SourceID | proquest crossref pubmed highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 5278 |
SubjectTerms | Animals Arthritis, Rheumatoid - genetics Arthritis, Rheumatoid - immunology Arthritis, Rheumatoid - physiopathology Crosses, Genetic Disease Models, Animal Female Genetic Markers - genetics Genetic Markers - immunology Genetic Predisposition to Disease - genetics Genome Injections, Intraperitoneal Male Mice Mice, Inbred BALB C Mice, Inbred C3H Mice, Inbred C57BL Polymorphism, Genetic - immunology Proteoglycans - administration & dosage Proteoglycans - immunology Quantitative Trait, Heritable Species Specificity Statistics, Nonparametric |
Title | A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis |
URI | http://www.jimmunol.org/cgi/content/abstract/165/9/5278 https://www.ncbi.nlm.nih.gov/pubmed/11046062 https://search.proquest.com/docview/17720925 https://search.proquest.com/docview/72362942 |
Volume | 165 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lRSAuCMor5TUHOJmkzsbPYwSpKtSGQw3qbbW216rV1EZx3Kic-OnM7Nqxi6iAA5coWttrx9-Xee3sDGNvpyjvEh4ko4zTMmOS2KMglJTv4Htx6vuuVBTTPTr1F2fBx7kzHwzaXoDd2H9FGscQa9o5-w9obyfFAfyOmOMnoo6ff4X7jJoil5fKqki-1ToUIK2ivFJLOkJ7Fi2tGq08NZlCqqK-4lZVVzrFRWfLXluo5HKTXrmStLiQFzgNxQmU6Z5DVubqXNVo8ZZ5SrWSznV9pL612-07M6UpaC-Kqfn0Tq-s2f0o73ptFoGsfspBka5QzV6oVbNc1R76igrFCLhtlPckv1DJ9y5y24Yy7GZPX088o2c88U1_jq14Nr0kGh6GPWHrctP9p1HcLjdFtX9VCg46QaQUmh85xgnH4bi7uF-Ce_FZHH45PhbR_CzaYXc4Si9qyHD6abFV757NnbYEPT2rKWVFNzn4zS1umjttCerb3Rlt1kQP2YMGHZgZIj1iA1XssbumQ-n1Hrt30uRePGY_ZmCYBcQs0MwCCZpZ0DAL9FNAxyxAZsFNZgExCxBZMMyCvMBpNLNAMwvKDDpmwZZZT1h0OI8-HI2a_h2jxLHD9SiUPlU9dlLJHXKM8W1lvkL_AI3Uqe9mE4-TjvPwNFQEAfrGMQ5mNk8kBdemT9luURbqOQO0YxMlMzdW8dSJpYxxwgx9bztQAZrs2ZC9b9-y-GaqtAj0bgkU0YIiEBQRCgJlyKBFQlSXcrlEBCZis9n0T3nTIiRQ4NIqmiwUvgoxQX_UDrl7-xk-R6swdPiQPTPQds9EGRW2x_f_eO0Ldr_7h7xku-tVrV6xnSqtX2s6_gSz2rPA |
link.rule.ids | 315,782,786,27934,27935 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+genome+scan+using+a+novel+genetic+cross+identifies+new+susceptibility+loci+and+traits+in+a+mouse+model+of+rheumatoid+arthritis&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Otto%2C+J+M&rft.au=Chandrasekeran%2C+R&rft.au=Vermes%2C+C&rft.au=Mikecz%2C+K&rft.date=2000-11-01&rft.issn=0022-1767&rft.volume=165&rft.issue=9&rft.spage=5278&rft.epage=5286&rft_id=info:doi/10.4049%2Fjimmunol.165.9.5278&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |